Your web browser is out of date.
For your security and improved experience online, please update your browser.
Diabetes on the Net is intended for healthcare professionals
Your web browser is out of date.
Diabetes on the Net is intended for healthcare professionals
Adapting our practice in unprecedented times
COVID-19 and the use of injectables
Tuesday 10 November 2020
at 1.00pm and 7.00pm
Join us for a live webinar where three of our most highly respected diabetes experts will consider the impact of COVID-19 on the diabetes population, their risk factors, and the role of GLP-1 receptor agonists in diabetes management.
During this webinar, Dr Patrick Holmes (GP/Partner, Darlington) will assess the impact of COVID-19 infection in individuals with diabetes, the data behind the observed increased risk of mortality, and current recommendations for diabetes management. Dr David Strain (Senior Lecturer University of Exeter Medical School), will then examine the use of GLP-1 receptor agonists when there is a compelling need to reduce weight or hypoglycaemia1, and then consider the clinical benefits of the GLP-1 receptor agonist Ozempic® (semaglutide).
Finally, we end the webinar with a unique discussion between Dr Patrick Holmes and Su Down (Diabetes Nurse Consultant, Somerset), on the value of initiating GLP-1 receptor agonists early in the course of diabetes and the practicalities and challenges of doing so remotely.
Reference 1. Buse JB et al (2020) Diabetes Care 43:487–93
Su Down is a Nurse Consultant in Diabetes and is the Clinical Lead for the Intermediate Diabetes community service in Somerset.
Nationally she is the Editor in Chief of the Journal of Diabetes Nursing and joint Vice Chair of the PCDS (Primary Care Diabetes Society). Former national roles have included being a TREND associate, board member of FIT (Forum for Injection Technique) and committee member of the Health Care Professionals Council of Diabetes UK.
The constant challenge of ensuring that an equitable service is delivered to the ever-growing population of Somerset is one that Su finds highly rewarding. Furthermore, she has relished being able to have an influence on both national and international projects.
Patrick Holmes has been a full-time GP/Partner in the same medical practice in the town of Darlington, in the North of England, for the past 19 years.
In addition to this, he works part-time as a GPwSI in Diabetes visiting a number of medical practices in the Derwentside area of County Durham. He has also been the local CCG diabetes lead for the past 12 years.
Dr David Strain is currently a Senior Clinical Lecturer at the University of Exeter Medical School, where he was successful in achieving a National Institute of Healthcare Research Clinical Senior Lecturer Award Fellowship. The fellowship allows Dr Strain to branch across diabetes and vascular research to continue his research into health and wellbeing in the older adult with diabetes. Prior to this, Dr Strain studied at Liverpool University before completing his Doctorate in Medicine on ‘The ethnic difference in the effects of insulin resistance on the vasculature’ at the International Centre for Cardiovascular Health, Imperial College, London.
His current research explores the mechanisms of action of different agents with the intention of seeing the right patient get the right agent. Additionally he runs a program focused on the correlation between patients’ interpretations of their quality of life and that of their relatives in decisions about their health. He was the global lead on a study determining the effect of individualised treatment targets in elderly patients with diabetes and is currently chairing the steering committee of a global project aiming to tackle clinical inertia in prescribing in association with the International Diabetes Federation (IDF) called ‘Time 2 Do More in Diabetes™’.
He has published over 120 peer reviewed publications and abstracts, and is currently an associate editor for the Journal of Diabetes Research responsible for mechanistic studies and Diabetic Medicine responsible for older adults.
Prescribing information for Ozempic®▼ (semaglutide) can be accessed by – LINK TO BE PROVIDED AT A LATER DATE
Date of prep: September 2020 – Job code: UK20OZM00117
get the latest news
subscribe now
© Copyright OmniaMed Communications. All Rights Reserved
We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.
